Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism

Pharmacological Reports

Volumn 67, Issue 3, 2015, Pages 569-580

  Smaga, Irena ^a   Niedzielska, Ewa ^a   Gawlik, Maciej ^a   Moniczewski, Andrzej ^a   Krzek, Jan ^a   Przegaliński, Edmund ^b   Pera, Joanna ^a   Filip, Małgorzata ^a,b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Animal study; Antioxidant defense molecule; Clinical study; Non enzymatic and enzymatic antioxidant; Oxidative biomarker

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIOXIDANT; ANXIOLYTIC AGENT; BIOLOGICAL MARKER; NEUROLEPTIC AGENT;

ANXIETY; ANXIETY DISORDER; AUTISM; CLINICAL TRIAL (TOPIC); DEPRESSION; HUMAN; MODULATION; NONHUMAN; OXIDATIVE STRESS; REVIEW; SCHIZOPHRENIA; ANIMAL; AUTISTIC DISORDER; DRUG DELIVERY SYSTEM; DRUG EFFECTS; MENTAL DISORDERS; METABOLISM; PHYSIOLOGY; PROCEDURES; TREATMENT OUTCOME; TRENDS;

ANIMALS; ANTIOXIDANTS; ANXIETY; AUTISTIC DISORDER; BIOMARKERS; CLINICAL TRIALS AS TOPIC; DEPRESSION; DRUG DELIVERY SYSTEMS; HUMANS; MENTAL DISORDERS; OXIDATIVE STRESS; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 84924330587     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2014.12.015     Document Type: Review

References (166)

1. American Psychiatric Association (APA) Diagnostic and statistical manual of mental disorders 5th ed. 2013 American Psychiatric Press Washington, DC
2. T.M. Michel, S. Frangou, D. Thiemeyer, S. Camara, J. Jecel, and K. Nara Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder - a postmortem study Psychiatry Res 151 1-2 2007 145 150
3. P. Galecki, J. Szemraj, M. Bienkiewicz, A. Florkowski, and E. Galecka Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment Pharmacol Rep 61 3 2009 436 447
4. M. Yumru, H.A. Savas, A. Kalenderoglu, M. Bulut, H. Celik, and O. Erel Oxidative imbalance in bipolar disorder subtypes: a comparative study Prog Neuropsychopharmacol Biol Psychiatry 33 6 2009 1070 1074
5. Y.C. Wei, F.L. Zhou, D.L. He, J.R. Bai, L.Y. Hui, and X.Y. Wang The level of oxidative stress and the expression of genes involved in DNA-damage signaling pathways in depressive patients with colorectal carcinoma J Psychosom Res 66 3 2009 259 266
6. F. Zhou, W. Zhang, Y. Wei, D. Zhou, Z. Su, and X. Meng The changes of oxidative stress and human 8-hydroxyguanine glycosylase1 gene expression in depressive patients with acute leukemia Leuk Res 31 3 2007 387 393
7. M. Maes, I. Mihaylova, M. Kubera, M. Uytterhoeven, N. Vrydags, and E. Bosmans Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery disease J Affect Disord 125 1-3 2010 287 294
8. S. Selek, H.A. Savas, H.S. Gergerlioglu, F. Bulbul, E. Uz, and M. Yumru The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode J Affect Disord 107 1-3 2008 89 94
9. A. Ikenouchi-Sugita, R. Yoshimura, H. Hori, W. Umene-Nakano, N. Ueda, and J. Nakamura Effects of antidepressants on plasma metabolites of nitric oxide in major depressive disorder: comparison between milnacipran and paroxetine Prog Neuropsychopharmacol Biol Psychiatry 33 8 2009 1451 1453
10. H. Herken, A. Gurel, S. Selek, F. Armutcu, M.E. Ozen, and M. Bulut Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment Arch Med Res 38 2 2007 247 252
11. M.E. Ozcan, M. Gulec, E. Ozerol, R. Polat, and O. Akyol Antioxidant enzyme activities and oxidative stress in affective disorders Int Clin Psychopharmacol 19 2 2004 89 95
12. Y.K. Kim, J.W. Paik, S.W. Lee, D. Yoon, C. Han, and B.H. Lee Increased plasma nitric oxide level associated with suicide attempt in depressive patients Prog Neuropsychopharmacol Biol Psychiatry 30 6 2006 1091 1096
13. T.M. Michel, S. Camara, T. Tatschner, S. Frangou, A.J. Sheldrick, and P. Riederer Increased xanthine oxidase in the thalamus and putamen in depression World J Biol Psychiatry 11 2 Pt 2 2010 314 320
14. S.D. Khanzode, G.N. Dakhale, S.S. Khanzode, A. Saoji, and R. Palasodkar Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors Redox Rep 8 6 2003 365 370
15. A. Sarandol, E. Sarandol, S.S. Eker, S. Erdinc, E. Vatansever, and S. Kirli Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems Hum Psychopharmacol 22 2 2007 67 73
16. A.C. Andreazza, C. Cassini, A.R. Rosa, M.C. Leite, L.M. de Almeida, and P. Nardin Serum S100B and antioxidant enzymes in bipolar patients J Psychiatr Res 41 6 2007 523 529
17. N. Dimopoulos, C. Piperi, V. Psarra, R.W. Lea, and A. Kalofoutis Increased plasma levels of 8-iso-PGF2alpha and IL-6 in an elderly population with depression Psychiatry Res 161 1 2008 59 66
18. M. Bilici, H. Efe, M.A. Koroglu, H.A. Uydu, M. Bekaroglu, and O. Deger Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments J Affect Disord 64 1 2001 43 51
19. C.P. Chung, D. Schmidt, C.M. Stein, J.D. Morrow, and R.M. Salomon Increased oxidative stress in patients with depression and its relationship to treatment Psychiatry Res 206 2-3 2013 213 216
20. Y. Milaneschi, M. Cesari, E.M. Simonsick, N. Vogelzangs, A.M. Kanaya, and K. Yaffe Lipid peroxidation and depressed mood in community-dwelling older men and women PLOS ONE 8 6 2013 e65406
21. S. Yager, M.J. Forlenza, and G.E. Miller Depression and oxidative damage to lipids Psychoneuroendocrinology 35 9 2010 1356 1362
22. M.J. Forlenza, and G.E. Miller Increased serum levels of 8-hydroxy-2′-deoxyguanosine in clinical depression Psychosom Med 68 1 2006 1 7
23. M. Irie, M. Miyata, and H. Kasai Depression and possible cancer risk due to oxidative DNA damage J Psychiatr Res 39 6 2005 553 560
24. M. Maes, I. Mihaylova, M. Kubera, M. Uytterhoeven, N. Vrydags, and E. Bosmans Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis/chronic fatigue syndrome Neuro Endocrinol Lett 30 6 2009 715 722
25. A.C. Andreazza, F. Kapczinski, M. Kauer-Sant'Anna, J.C. Walz, D.J. Bond, and C.A. Goncalves 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder J Psychiatry Neurosci 34 4 2009 263 271
26. J.F. Wang, L. Shao, X. Sun, and L.T. Young Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia Bipolar Disord 11 5 2009 523 529
27. A.C. Andreazza, L. Shao, J.F. Wang, and L.T. Young Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder Arch Gen Psychiatry 67 4 2010 360 368
28. Y. Che, J.F. Wang, L. Shao, and T. Young Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness J Psychiatry Neurosci 35 5 2010 296 302
29. B.E. Cumurcu, H. Ozyurt, I. Etikan, S. Demir, and R. Karlidag Total antioxidant capacity and total oxidant status in patients with major depression: impact of antidepressant treatment Psychiatry Clin Neurosci 63 5 2009 639 645
30. J. Kodydkova, L. Vavrova, M. Zeman, R. Jirak, J. Macasek, and B. Stankova Antioxidative enzymes and increased oxidative stress in depressive women Clin Biochem 42 13-14 2009 1368 1374
31. M. Maes, I. Mihaylova, M. Kubera, M. Uytterhoeven, N. Vrydags, and E. Bosmans Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness Neuro Endocrinol Lett 30 4 2009 462 469
32. H. Tsuboi, A. Tatsumi, K. Yamamoto, F. Kobayashi, K. Shimoi, and N. Kinae Possible connections among job stress, depressive symptoms, lipid modulation and antioxidants J Affect Disord 91 1 2006 63 70
33. P. Galecki, J. Szemraj, M. Bienkiewicz, K. Zboralski, and E. Galecka Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients Hum Psychopharmacol 24 4 2009 277 286
34. M. Peet, and D.F. Horrobin A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs Arch Gen Psychiatry 59 10 2002 913 919
35. M. Berk, D.L. Copolov, O. Dean, K. Lu, S. Jeavons, and I. Schapkaitz N-acetyl cysteine for depressive symptoms in bipolar disorder - a double-blind randomized placebo-controlled trial Biol Psychiatry 64 6 2008 468 475
36. M. Berk, O. Dean, S.M. Cotton, C.S. Gama, F. Kapczinski, and B.S. Fernandes The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial J Affect Disord 135 1-3 2011 389 394
37. P.V. Magalhaes, O.M. Dean, A.I. Bush, D.L. Copolov, G.S. Malhi, and K. Kohlmann N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial J Affect Disord 129 1-3 2011 317 320
38. P.V. Magalhaes, O.M. Dean, A.I. Bush, D.L. Copolov, G.S. Malhi, and K. Kohlmann N-acetylcysteine for major depressive episodes in bipolar disorder Rev Bras Psiquiatr 33 4 2011 374 378
39. A.F. Carvalho, D.S. Macedo, P. Goulia, and T.N. Hyphantis N-acetylcysteine augmentation to tranylcypromine in treatment-resistant major depression J Clin Psychopharmacol 33 5 2013 719 720
40. G. Lucca, C.M. Comim, S.S. Valvassori, G.Z. Reus, F. Vuolo, and F. Petronilho Effects of chronic mild stress on the oxidative parameters in the rat brain Neurochem Int 54 5-6 2009 358 362
41. H.M. Abelaira, G.Z. Reus, K.F. Ribeiro, A.V. Steckert, F. Mina, and D.V. Rosa Effects of lamotrigine on behavior, oxidative parameters and signaling cascades in rats exposed to the chronic mild stress model Neurosci Res 75 4 2013 324 330
42. M. Naziroglu, S. Kozlu, E. Yorgancigil, A.C. Uguz, and K. Karakus Rose oil (from Rosa × damascena Mill.) vapor attenuates depression-induced oxidative toxicity in rat brain J Nat Med 67 1 2013 152 158
43. C.O. Arent, G.Z. Reus, H.M. Abelaira, K.F. Ribeiro, A.V. Steckert, and F. Mina Synergist effects of n-acetylcysteine and deferoxamine treatment on behavioral and oxidative parameters induced by chronic mild stress in rats Neurochem Int 61 7 2012 1072 1080
44. M.F. Schaalan, and N.N. Nassar Effects of octreotide in chronically mild stressed rats: possible role of immune and oxidative stress pathways Neurochem Res 36 10 2011 1717 1723
45. I. Eren, M. Naziroglu, and A. Demirdas Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain Neurochem Res 32 7 2007 1188 1195
46. I. Eren, M. Naziroglu, A. Demirdas, O. Celik, A.C. Uguz, and A. Altunbasak Venlafaxine modulates depression-induced oxidative stress in brain and medulla of rat Neurochem Res 32 3 2007 497 505
47. G. Lucca, C.M. Comim, S.S. Valvassori, G.Z. Reus, F. Vuolo, and F. Petronilho Increased oxidative stress in submitochondrial particles into the brain of rats submitted to the chronic mild stress paradigm J Psychiatr Res 43 9 2009 864 869
48. B. Kumar, A. Kuhad, and K. Chopra Neuropsychopharmacological effect of sesamol in unpredictable chronic mild stress model of depression: behavioral and biochemical evidences Psychopharmacology (Berl) 214 4 2011 819 828
49. D. Zhang, X.S. Wen, X.Y. Wang, M. Shi, and Y. Zhao Antidepressant effect of Shudihuang on mice exposed to unpredictable chronic mild stress J Ethnopharmacol 123 1 2009 55 60
50. F.G. de Souza, M.D. Rodrigues, S. Tufik, J.N. Nobrega, and V. D'Almeida Acute stressor-selective effects on homocysteine metabolism and oxidative stress parameters in female rats Pharmacol Biochem Behav 85 2 2006 400 407
51. A. Zafir, and N. Banu Antioxidant potential of fluoxetine in comparison to Curcuma longa in restraint-stressed rats Eur J Pharmacol 572 1 2007 23 31
52. A. Zafir, and N. Banu Modulation of in vivo oxidative status by exogenous corticosterone and restraint stress in rats Stress 12 2 2009 167 177
53. R. Garg, and A. Kumar Possible role of citalopram and desipramine against sleep deprivation-induced anxiety like-behavior alterations and oxidative damage in mice Indian J Exp Biol 46 11 2008 770 776
54. I. Tasset, J. Pena, I. Jimena, M. Feijoo, M. Del Carmen Munoz, and P. Montilla Effect of 17beta-estradiol on olfactory bulbectomy-induced oxidative stress and behavioral changes in rats Neuropsychiatr Dis Treat 4 2 2008 441 449
55. I. Tasset, R. Drucker-Colin, J. Pena, I. Jimena, P. Montilla, and F.J. Medina Antioxidant-like effects and protective action of transcranial magnetic stimulation in depression caused by olfactory bulbectomy Neurochem Res 35 8 2010 1182 1187
56. I. Tasset, F.J. Medina, J. Pena, I. Jimena, M. Del Carmen Munoz, and M. Salcedo Olfactory bulbectomy induced oxidative and cell damage in rat: protective effect of melatonin Physiol Res 59 1 2010 105 112
57. I. Tunez, R. Drucker-Colin, P. Montilla, J. Pena, I. Jimena, and F.J. Medina Protective effect of nicotine on oxidative and cell damage in rats with depression induced by olfactory bulbectomy Eur J Pharmacol 627 1-3 2010 115 118
58. N. Boufleur, C.T. Antoniazzi, C.S. Pase, D.M. Benvegnu, V.T. Dias, and H.J. Segat Neonatal handling prevents anxiety-like symptoms in rats exposed to chronic mild stress: behavioral and oxidative parameters Stress 16 3 2013 321 330
59. S. Aboul-Fotouh Coenzyme Q10 displays antidepressant-like activity with reduction of hippocampal oxidative/nitrosative DNA damage in chronically stressed rats Pharmacol Biochem Behav 104 2013 105 112
60. R.M. Santiago, J. Barbiero, B.J. Martynhak, S.L. Boschen, L.M. da Silva, and M.F. Werner Antidepressant-like effect of celecoxib piroxicam in rat models of depression J Neural Transm 121 6 2014 671 682
61. I. Smaga, B. Pomierny, W. Krzyzanowska, L. Pomierny-Chamiolo, J. Miszkiel, and E. Niedzielska N-acetylcysteine possesses antidepressant-like activity through reduction of oxidative stress: behavioral and biochemical analyses in rats Prog Neuropsychopharmacol Biol Psychiatry 39 2 2012 280 287
62. F.P. Della, H.M. Abelaira, G.Z. Reus, A.R. Antunes, M.A. Dos Santos, and G. Zappelinni Tianeptine exerts neuroprotective effects in the brain tissue of rats exposed to the chronic stress model Pharmacol Biochem Behav 103 2 2012 395 402
63. A. Zafir, A. Ara, and N. Banu Invivo antioxidant status: a putative target of antidepressant action Prog Neuropsychopharmacol Biol Psychiatry 33 2 2009 220 228
64. A. Kumar, and R. Garg Protective effects of antidepressants against chronic fatigue syndrome-induced behavioral changes and biochemical alterations Fundam Clin Pharmacol 23 1 2009 89 95
65. M. Atmaca, M. Kuloglu, E. Tezcan, and B. Ustundag Antioxidant enzyme and malondialdehyde levels in patients with social phobia Psychiatry Res 159 1-2 2008 95 100
66. M. Kuloglu, M. Atmaca, E. Tezcan, B. Ustundag, and S. Bulut Antioxidant enzyme and malondialdehyde levels in patients with panic disorder Neuropsychobiology 46 4 2002 186 189
67. E. Ozdemir, S. Cetinkaya, S. Ersan, S. Kucukosman, and E.E. Ersan Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive-compulsive disorder Prog Neuropsychopharmacol Biol Psychiatry 33 1 2009 62 65
68. M. Kuloglu, M. Atmaca, E. Tezcan, O. Gecici, H. Tunckol, and B. Ustundag Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder Neuropsychobiology 46 1 2002 27 32
69. E. Tezcan, M. Atmaca, M. Kuloglu, and B. Ustundag Free radicals in patients with post-traumatic stress disorder Eur Arch Psychiatry Clin Neurosci 253 2 2003 89 91
70. J.R. Strawn, and S.N. Saldana Treatment with adjunctive N-acetylcysteine in an adolescent with selective serotonin reuptake inhibitor-resistant anxiety J Child Adolesc Psychopharmacol 22 6 2012 472 473
71. H. Rammal, J. Bouayed, C. Younos, and R. Soulimani Evidence that oxidative stress is linked to anxiety-related behaviour in mice Brain Behav Immun 22 8 2008 1156 1159
72. S. Salim, N. Sarraj, M. Taneja, K. Saha, M.V. Tejada-Simon, and G. Chugh Moderate treadmill exercise prevents oxidative stress-induced anxiety-like behavior in rats Behav Brain Res 208 2 2010 545 552
73. H. Rammal, J. Bouayed, C. Younos, and R. Soulimani The impact of high anxiety level on the oxidative status of mouse peripheral blood lymphocytes, granulocytes and monocytes Eur J Pharmacol 589 1-3 2008 173 175
74. A. Masood, A. Nadeem, S.J. Mustafa, and J.M. O'Donnell Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice J Pharmacol Exp Ther 326 2 2008 369 379
75. M.R. de Oliveira, R.B. Silvestrin, E.S.T. Mello, and J.C. Moreira Oxidative stress in the hippocampus, anxiety-like behavior and decreased locomotory and exploratory activity of adult rats: effects of sub acute vitamin A supplementation at therapeutic doses Neurotoxicology 28 6 2007 1191 1199
76. C. Desrumaux, P.Y. Risold, H. Schroeder, V. Deckert, D. Masson, and A. Athias Phospholipid transfer protein (PLTP) deficiency reduces brain vitamin E content and increases anxiety in mice FASEB J 19 2 2005 296 297
77. A. Berry, F. Capone, M. Giorgio, P.G. Pelicci, E.R. de Kloet, and E. Alleva Deletion of the life span determinant p66Shc prevents age-dependent increases in emotionality and pain sensitivity in mice Exp Gerontol 42 1-2 2007 37 45
78. I. Hovatta, R.S. Tennant, R. Helton, R.A. Marr, O. Singer, and J.M. Redwine Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice Nature 438 7068 2005 662 666
79. S.A. Kromer, M.S. Kessler, D. Milfay, I.N. Birg, M. Bunck, and L. Czibere Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety J Neurosci 25 17 2005 4375 4384
80. R. Goyal, and K. Anil Protective effect of alprazolam in acute immobilization stress-induced certain behavioral and biochemical alterations in mice Pharmacol Rep 59 3 2007 284 290
81. A. Singh, and A. Kumar Protective effect of alprazolam against sleep deprivation-induced behavior alterations and oxidative damage in mice Neurosci Res 60 4 2008 372 379
82. A. Kumar, and R. Goyal Possible GABAergic modulation in the protective effect of zolpidem in acute hypoxic stress-induced behavior alterations and oxidative damage Neurochem Res 33 3 2008 370 377
83. A. Kumar, G. Kaur, H. Kalonia, and P. Rinwa Evaluation of sesamol and buspirone in stress induced anxiety in mice Indian J Pharmacol 45 1 2013 49 53
84. L.A. Mendez-Cuesta, B. Marquez-Valadez, V. Perez-De La Cruz, C. Escobar-Briones, S. Galvan-Arzate, and Y. Alvarez-Ruiz Diazepam blocks striatal lipid peroxidation and improves stereotyped activity in a rat model of acute stress Basic Clin Pharmacol Toxicol 109 5 2011 350 356
85. K. Matsumoto, K. Yobimoto, N.T. Huong, M. Abdel-Fattah, T. Van Hien, and H. Watanabe Psychological stress-induced enhancement of brain lipid peroxidation via nitric oxide systems and its modulation by anxiolytic and anxiogenic drugs in mice Brain Res 839 1 1999 74 84
86. S. Musavi, and P. Kakkar Effect of diazepam treatment and its withdrawal on pro/antioxidative processes in rat brain Mol Cell Biochem 245 1-2 2003 51 56
87. N. Egashira, A. Shirakawa, M. Abe, T. Niki, K. Mishima, and K. Iwasaki N-acetyl-l-cysteine inhibits marble-burying behavior in mice J Pharmacol Sci 119 1 2012 97 101
88. J.E. Grant, B.L. Odlaug, and S.W. Kim N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study Arch Gen Psychiatry 66 7 2009 756 763
89. M.O. Akiibinu, O.A. Ogundahunsi, and E.O. Ogunyemi Inter-relationship of plasma markers of oxidative stress and thyroid hormones in schizophrenics BMC Res Notes 5 2012 169
90. F. Taneli, S. Pirildar, F. Akdeniz, B.S. Uyanik, and Z. Ari Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia Arch Med Res 35 5 2004 401 405
91. A. Sarandol, S. Kirli, C. Akkaya, A. Altin, M. Demirci, and E. Sarandol Oxidative-antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: effects of short term antipsychotic treatment Prog Neuropsychopharmacol Biol Psychiatry 31 6 2007 1164 1169
92. M. Padurariu, A. Ciobica, I. Dobrin, and C. Stefanescu Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics Neurosci Lett 479 3 2010 317 320
93. X.Y. Zhang, Y.L. Tan, L.Y. Cao, G.Y. Wu, Q. Xu, and Y. Shen Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics Schizophr Res 81 2-3 2006 291 300
94. C.S. Gama, M. Salvador, A.C. Andreazza, F. Kapczinski, and P. Silva Belmonte-de-Abreu Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine Prog Neuropsychopharmacol Biol Psychiatry 30 3 2006 512 515
95. A. Dietrich-Muszalska, and B. Olas Isoprostenes as indicators of oxidative stress in schizophrenia World J Biol Psychiatry 10 1 2009 27 33
96. A. Dietrich-Muszalska, B. Olas, R. Glowacki, and E. Bald Oxidative/nitrative modifications of plasma proteins and thiols from patients with schizophrenia Neuropsychobiology 59 1 2009 1 7
97. V.S. Catts, S.V. Catts, A. Jablensky, D. Chandler, C.S. Weickert, and M.F. Lavin Evidence of aberrant DNA damage response signalling but normal rates of DNA repair in dividing lymphoblasts from patients with schizophrenia World J Biol Psychiatry 13 2 2012 114 125
98. A. Jorgensen, K. Broedbaek, A. Fink-Jensen, U. Knorr, M. Greisen Soendergaard, and T. Henriksen Increased systemic oxidatively generated DNA and RNA damage in schizophrenia Psychiatry Res 209 3 2013 417 423
99. J.K. Yao, S. Leonard, and R.D. Reddy Increased nitric oxide radicals in postmortem brain from patients with schizophrenia Schizophr Bull 30 4 2004 923 934
100. T.M. Michel, A.J. Sheldrick, S. Camara, E. Grunblatt, F. Schneider, and P. Riederer Alteration of the pro-oxidant xanthine oxidase (XO) in the thalamus and occipital cortex of patients with schizophrenia World J Biol Psychiatry 12 8 2011 588 597
101. K.Q. Do, A.H. Trabesinger, M. Kirsten-Kruger, C.J. Lauer, U. Dydak, and D. Hell Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo Eur J Neurosci 12 10 2000 3721 3728
102. D. Matsuzawa, and K. Hashimoto Magnetic resonance spectroscopy study of the antioxidant defense system in schizophrenia Antioxid Redox Signal 15 7 2011 2057 2065
103. H. Bentsen, D.K. Solberg, H. Refsum, J.M. Gran, T. Bohmer, and P.A. Torjesen Bimodal distribution of polyunsaturated fatty acids in schizophrenia suggests two endophenotypes of the disorder Biol Psychiatry 70 1 2011 97 105
104. X.Y. Zhang, D.F. Zhou, L.Y. Cao, P.Y. Zhang, and G.Y. Wu Elevated blood superoxide dismutase in neuroleptic-free schizophrenia: association with positive symptoms Psychiatry Res 117 1 2003 85 88
105. M. Zhang, Z. Zhao, L. He, and C. Wan A meta-analysis of oxidative stress markers in schizophrenia Sci China Life Sci 53 1 2010 112 124
106. P.K. Ranjekar, A. Hinge, M.V. Hegde, M. Ghate, A. Kale, and S. Sitasawad Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients Psychiatry Res 121 2 2003 109 122
107. J.K. Yao, R. Reddy, L.G. McElhinny, and D.P. van Kammen Effects of haloperidol on antioxidant defense system enzymes in schizophrenia J Psychiatr Res 32 6 1998 385 391
108. H. Herken, E. Uz, H. Ozyurt, S. Sogut, O. Virit, and O. Akyol Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia Mol Psychiatry 6 1 2001 66 73
109. M. Raffa, A. Mechri, L.B. Othman, C. Fendri, L. Gaha, and A. Kerkeni Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients Prog Neuropsychopharmacol Biol Psychiatry 33 7 2009 1178 1183
110. S.J. Wood, G.E. Berger, R.M. Wellard, T.M. Proffitt, M. McConchie, and M. Berk Medial temporal lobe glutathione concentration in first episode psychosis: a 1H-MRS investigation Neurobiol Dis 33 3 2009 354 357
111. D. Matsuzawa, T. Obata, Y. Shirayama, H. Nonaka, Y. Kanazawa, and E. Yoshitome Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS study PLoS ONE 3 4 2008 e1944
112. J.W. Gawryluk, J.F. Wang, A.C. Andreazza, L. Shao, and L.T. Young Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders Int J Neuropsychopharmacol 14 1 2011 123 130
113. J.K. Yao, S. Leonard, and R. Reddy Altered glutathione redox state in schizophrenia Dis Markers 22 1-2 2006 83 93
114. J.W. Gawryluk, J.F. Wang, A.C. Andreazza, L. Shao, L.N. Yatham, and L.T. Young Prefrontal cortex glutathione S-transferase levels in patients with bipolar disorder, major depression and schizophrenia Int J Neuropsychopharmacol 14 8 2011 1069 1074
115. C. Miljevic, M. Nikolic, A. Nikolic-Kokic, D.R. Jones, V. Niketic, and D. Lecic-Tosevski Lipid status, anti-oxidant enzyme defence and haemoglobin content in the blood of long-term clozapine-treated schizophrenic patients Prog Neuropsychopharmacol Biol Psychiatry 34 2 2010 303 307
116. S. Kropp, V. Kern, K. Lange, D. Degner, G. Hajak, and J. Kornhuber Oxidative stress during treatment with first- and second-generation antipsychotics J Neuropsychiatry Clin Neurosci 17 2 2005 227 231
117. M. Bulut, H.A. Savas, A. Altindag, O. Virit, and A. Dalkilic Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia World J Biol Psychiatry 10 4 Pt 2 2009 626 628
118. S. Lavoie, M.M. Murray, P. Deppen, M.G. Knyazeva, M. Berk, and O. Boulat Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients Neuropsychopharmacology 33 9 2008 2187 2199
119. M. Berk, D. Copolov, O. Dean, K. Lu, S. Jeavons, and I. Schapkaitz N-acetyl cysteine as a glutathione precursor for schizophrenia - a double-blind, randomized, placebo-controlled trial Biol Psychiatry 64 5 2008 361 368
120. C. Carmeli, M.G. Knyazeva, M. Cuenod, and K.Q. Do Glutathione precursor N-acetyl-cysteine modulates EEG synchronization in schizophrenia patients: a double-blind, randomized, placebo-controlled trial PLoS ONE 7 2 2012 e29341
121. M. Farokhnia, A. Azarkolah, F. Adinehfar, M.R. Khodaie-Ardakani, S.M. Hosseini, and H. Yekehtaz N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study Clin Neuropharmacol 36 6 2013 185 192
122. G.P. Amminger, M.R. Schafer, K. Papageorgiou, C.M. Klier, S.M. Cotton, and S.M. Harrigan Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial Arch Gen Psychiatry 67 2 2010 146 154
123. M. Arvindakshan, M. Ghate, P.K. Ranjekar, D.R. Evans, and S.P. Mahadik Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia Schizophr Res 62 3 2003 195 204
124. N.V. Radonjic, I.D. Knezevic, U. Vilimanovich, T. Kravic-Stevovic, L.V. Marina, and T. Nikolic Decreased glutathione levels and altered antioxidant defense in an animal model of schizophrenia: long-term effects of perinatal phencyclidine administration Neuropharmacology 58 4-5 2010 739 745
125. V.S. Rao, A.C. Carvalho, M.T. Trevisan, G.M. Andrade, H.V. Nobre-Junior, and M.O. Moraes Mangiferin ameliorates 6-hydroxydopamine-induced cytotoxicity and oxidative stress in ketamine model of schizophrenia Pharmacol Rep 64 4 2012 848 856
126. L. de Oliveira, C.M. Spiazzi, T. Bortolin, L. Canever, F. Petronilho, and F.G. Mina Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats Prog Neuropsychopharmacol Biol Psychiatry 33 6 2009 1003 1008
127. M.M. Behrens, S.S. Ali, D.N. Dao, J. Lucero, G. Shekhtman, and K.L. Quick Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase Science 318 5856 2007 1645 1647
128. D.M. Otte, B. Sommersberg, A. Kudin, C. Guerrero, O. Albayram, and M.D. Filiou N-acetyl cysteine treatment rescues cognitive deficits induced by mitochondrial dysfunction in G72/G30 transgenic mice Neuropsychopharmacology 36 11 2011 2233 2243
129. Z. Jiang, G.R. Rompala, S. Zhang, R.M. Cowell, and K. Nakazawa Social isolation exacerbates schizophrenia-like phenotypes via oxidative stress in cortical interneurons Biol Psychiatry 73 10 2013 1024 1034
130. Y. Yang, M.Z. Dieter, Y. Chen, H.G. Shertzer, D.W. Nebert, and T.P. Dalton Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm(-/-) knockout mouse. Novel model system for a severely compromised oxidative stress response J Biol Chem 277 51 2002 49446 49452
131. M.D. Filiou, L. Teplytska, D.M. Otte, A. Zimmer, and C.W. Turck Myelination and oxidative stress alterations in the cerebellum of the G72/G30 transgenic schizophrenia mouse model J Psychiatr Res 46 10 2012 1359 1365
132. V. Parikh, M.M. Khan, and S.P. Mahadik Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain J Psychiatr Res 37 1 2003 43 51
133. A. Pillai, V. Parikh, A.V. Terry Jr., and S.P. Mahadik Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain J Psychiatr Res 41 5 2007 372 386
134. M.R. Martins, F.C. Petronilho, K.M. Gomes, F. Dal-Pizzol, E.L. Streck, and J. Quevedo Antipsychotic-induced oxidative stress in rat brain Neurotox Res 13 1 2008 63 69
135. J.M. das Neves Duarte, A. Kulak, M.M. Gholam-Razaee, M. Cuenod, R. Gruetter, and K.Q. Do N-acetylcysteine normalizes neurochemical changes in the glutathione-deficient schizophrenia mouse model during development Biol Psychiatry 71 11 2012 1006 1014
136. J.H. Cabungcal, P. Steullet, R. Kraftsik, M. Cuenod, and K.Q. Do Early-life insults impair parvalbumin interneurons via oxidative stress: reversal by N-acetylcysteine Biol Psychiatry 73 6 2013 574 582
137. A.I. Zugno, H.L. Chipindo, A.M. Volpato, J. Budni, A.V. Steckert, and M.B. de Oliveira Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia Neuroscience 259 2014 223 231
138. R. Deth, C. Muratore, J. Benzecry, V.A. Power-Charnitsky, and M. Waly How environmental and genetic factors combine to cause autism: a redox/methylation hypothesis Neurotoxicology 29 1 2008 190 201
139. L. Ciccoli, C. De Felice, E. Paccagnini, S. Leoncini, A. Pecorelli, and C. Signorini Erythrocyte shape abnormalities, membrane oxidative damage, and beta-actin alterations: an unrecognized triad in classical autism Mediat Inflamm 2013 2013 432616
140. A. El-Ansary, and L. Al-Ayadhi Lipid mediators in plasma of autism spectrum disorders Lipids Health Dis 11 2012 160
141. N.A. Meguid, A.A. Dardir, E.R. Abdel-Raouf, and A. Hashish Evaluation of oxidative stress in autism: defective antioxidant enzymes and increased lipid peroxidation Biol Trace Elem Res 143 1 2011 58 65
142. M.M. Essa, G.J. Guillemin, M.I. Waly, M.M. Al-Sharbati, Y.M. Al-Farsi, and F.L. Hakkim Increased markers of oxidative stress in autistic children of the Sultanate of Oman Biol Trace Elem Res 147 1-3 2012 25 27
143. J. Frackowiak, B. Mazur-Kolecka, N.C. Schanen, W.T. Brown, and J. Wegiel The link between intraneuronal N-truncated amyloid-beta peptide and oxidatively modified lipids in idiopathic autism and dup(15q11.2-q13)/autism Acta Neuropathol Commun 1 1 2013 61
144. S. Sogut, S.S. Zoroglu, H. Ozyurt, H.R. Yilmaz, F. Ozugurlu, and E. Sivasli Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism Clin Chim Acta 331 1-2 2003 111 117
145. A. Chauhan, F. Gu, M.M. Essa, J. Wegiel, K. Kaur, and W.T. Brown Brain region-specific deficit in mitochondrial electron transport chain complexes in children with autism J Neurochem 117 2 2011 209 220
146. B. Muthaiyah, M.M. Essa, V. Chauhan, W.T. Brown, J. Wegiel, and A. Chauhan Increased lipid peroxidation in cerebellum and temporal cortex of brain in autism J Neurochem 108 Suppl. 1 2009
147. E.M. Sajdel-Sulkowska, M. Xu, and N. Koibuchi Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism Cerebellum 8 3 2009 366 372
148. E.M. Sajdel-Sulkowska, M. Xu, W. McGinnis, and N. Koibuchi Brain region-specific changes in oxidative stress and neurotrophin levels in autism spectrum disorders (ASD) Cerebellum 10 1 2011 43 48
149. A. Chauhan, T. Audhya, and V. Chauhan Increased DNA oxidation in the cerebellum, frontal and temporal cortex of brain in autism. Transactions of the American Society for Neurochemistry 2011 American Society for Neurochemistry Windermere 81
150. O. Yorbik, A. Sayal, C. Akay, D.I. Akbiyik, and T. Sohmen Investigation of antioxidant enzymes in children with autistic disorder Prostaglandins Leukot Essent Fatty Acids 67 5 2002 341 343
151. A. Laszlo, Z. Novak, I. Szollosi-Varga, Q. Hai du, A. Vetro, and A. Kovacs Blood lipid peroxidation, antioxidant enzyme activities and hemorheological changes in autistic children Ideggyogy Sz 66 1-2 2013 23 28
152. L. Vergani, L. Cristina, R. Paola, A.M. Luisa, G. Shyti, and V. Edvige Metals, metallothioneins and oxidative stress in blood of autistic children Res Autism Spectr Disord 5 1 2011 286 293
153. Y. Al-Gadani, A. El-Ansary, O. Attas, and L. Al-Ayadhi Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children Clin Biochem 42 10-11 2009 1032 1040
154. S.S. Zoroglu, F. Armutcu, S. Ozen, A. Gurel, E. Sivasli, and O. Yetkin Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism Eur Arch Psychiatry Clin Neurosci 254 3 2004 143 147
155. G.A. Mostafa, E.S. El-Hadidi, D.H. Hewedi, and M.M. Abdou Oxidative stress in Egyptian children with autism: relation to autoimmunity J Neuroimmunol 219 1-2 2010 114 118
156. D.A. Geier, J.K. Kern, C.R. Garver, J.B. Adams, T. Audhya, and M.R. Geier A prospective study of transsulfuration biomarkers in autistic disorders Neurochem Res 34 2 2009 386 393
157. S.J. James, S. Melnyk, S. Jernigan, M.A. Cleves, C.H. Halsted, and D.H. Wong Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism Am J Med Genet B Neuropsychiatr Genet 141b 8 2006 947 956
158. A.Y. Hardan, L.K. Fung, R.A. Libove, T.V. Obukhanych, S. Nair, and L.A. Herzenberg A randomized controlled pilot trial of oral N-acetylcysteine in children with autism Biol Psychiatry 71 11 2012 956 961
159. A. Gvozdjakova, J. Kucharska, D. Ostatnikova, K. Babinska, D. Nakladal, and F.L. Crane Ubiquinol improves symptoms in children with autism Oxid Med Cell Longev 2014 2014 798957
160. M.C. Dolske, J. Spollen, S. McKay, E. Lancashire, and L. Tolbert A preliminary trial of ascorbic acid as supplemental therapy for autism Prog Neuropsychopharmacol Biol Psychiatry 17 5 1993 765 774
161. A. Ghanizadeh, and E. Moghimi-Sarani A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders BMC Psychiatry 13 2013 196
162. J.W. Hunter, G.P. Mullen, J.R. McManus, J.M. Heatherly, A. Duke, and J.B. Rand Neuroligin-deficient mutants of C. elegans have sensory processing deficits and are hypersensitive to oxidative stress and mercury toxicity Dis Model Mech 3 5-6 2010 366 376
163. D.F. MacFabe, K. Rodríguez-Capote, J.E. Hoffman, A.E. Franklin, Y. Mohammad-Asef, and A.R. Taylor A novel rodent model of autism: intraventricular infusions of propionic acid increase locomotor activity and induce neuroinflammation and oxidative stress in discrete regions of adult rat brain Am J Biochem Biotechnol 4 2 2008 146 166
164. B. Pragnya, J.S. Kameshwari, and B. Veeresh Ameliorating effect of piperine on behavioral abnormalities and oxidative markers in sodium valproate induced autism in BALB/C mice Behav Brain Res 270c 2014 86 94
165. E.G. Bechara, M.C. Didiot, M. Melko, L. Davidovic, M. Bensaid, and P. Martin A novel function for fragile X mental retardation protein in translational activation PLoS Biol 7 1 2009 e16
166. C.L. Yochum, P. Bhattacharya, L. Patti, O. Mirochnitchenko, and G.C. Wagner Animal model of autism using GSTM1 knockout mice and early post-natal sodium valproate treatment Behav Brain Res 210 2 2010 202 210